Tetracycline/OVA is an antigen-adjuvant conjugate formed by linking Tetracycline with chicken egg albumin (OVA). This conjugation enhances the production of antigen-specific antibodies in vaccine models without altering protein folding or disrupting major epitopes. Additionally, it promotes cross-presentation and the generation of antigen-specific T cells.